-
Je něco špatně v tomto záznamu ?
The PanCareFollowUp Care Intervention: A European harmonised approach to person-centred guideline-based survivorship care after childhood, adolescent and young adult cancer
RJ. van Kalsbeek, RL. Mulder, R. Haupt, M. Muraca, L. Hjorth, C. Follin, T. Kepak, K. Kepakova, A. Uyttebroeck, M. Mangelschots, J. Falck Winther, JJ. Loonen, G. Michel, E. Bardi, L. Elmerdahl Frederiksen, J. den Hartogh, L. Mader, K. Roser, C....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- kvalita života MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- nádory * terapie MeSH
- období po vyléčení MeSH
- přežívající onkologičtí pacienti * MeSH
- přežívající MeSH
- Check Tag
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Long-term follow-up (LTFU) care, although endorsed, is not available for the majority of adult survivors of childhood, adolescence and young adult (CAYA) cancer. Barriers to implementation include lack of time, knowledge, personnel and funding. Sustainable solutions are urgently needed to address the needs of CAYA cancer survivors to improve the quality of life and reduce the burden of late effects on survivors, health care systems and society. The European Union-funded PanCareFollowUp project, initiated by the Pan-European Network for Care of Survivors after Childhood and Adolescent Cancer, was established to facilitate the implementation of person-centred survivorship care across Europe. PATIENTS AND METHODS: The PanCareFollowUp Care Intervention was co-developed with survivors as part of the PanCareFollowUp project. It is a person-centred approach to survivorship care, supported by guidelines and with flexibility to adapt to local health care settings. The Care Intervention consists of three steps: (1) previsit completion of a Survivor Questionnaire (by the survivor) and Treatment Summary (by the health care provider [HCP]), (2) a clinic visit including shared decision-making, and (3) a follow-up call to finalise the individualised Survivorship Care Plan. RESULTS: We developed the key components of the PanCareFollowUp Care Intervention: a PanCareFollowUp Survivor Questionnaire, Treatment Summary template, Survivorship Care Plan template, and educational materials for HCPs and survivors. Wide implementation of the PanCareFollowUp Care Intervention will be supported with a freely distributed Replication Manual on completion of the PanCareFollowUp project. CONCLUSIONS: The PanCareFollowUp Care Intervention will support the implementation of person-centred, guideline-based LTFU care in different health care settings across Europe to improve survivors' health and well-being.
Childhood Cancer International Europe Vienna Austria
Childhood Cancer Research Group Danish Cancer Society Research Centre Copenhagen Denmark
Department of Health Sciences and Medicine University of Lucerne Lucerne Switzerland
Department of Paediatrics Emma Children's Hospital Amsterdam UMC Amsterdam the Netherlands
Department of Pediatric and Adolescent Medicine Kepler University Clinic Linz Austria
Epidemiology and Biostatistics Unit and DOPO Clinic IRCCS Istituto Giannina Gaslini Genoa Italy
Faculty of Medicine Utrecht University and Utrecht Medical Centre Utrecht the Netherlands
Great North Children's Hospital Royal Victoria Infirmary Newcastle Upon Tyne United Kingdom
Institute of Social and Preventive Medicine University of Bern Bern Switzerland
Lund University Skane University Hospital Department of Clinical Sciences Lund Oncology Lund Sweden
Netherlands Institute for Health Services Research Utrecht the Netherlands
PanCare Bussum the Netherlands
Princess Máxima Centre for Paediatric Oncology Utrecht the Netherlands
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22019420
- 003
- CZ-PrNML
- 005
- 20240219150832.0
- 007
- ta
- 008
- 220720e20211222xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejca.2021.10.035 $2 doi
- 035 __
- $a (PubMed)34953441
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a van Kalsbeek, Rebecca J $u Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands
- 245 14
- $a The PanCareFollowUp Care Intervention: A European harmonised approach to person-centred guideline-based survivorship care after childhood, adolescent and young adult cancer / $c RJ. van Kalsbeek, RL. Mulder, R. Haupt, M. Muraca, L. Hjorth, C. Follin, T. Kepak, K. Kepakova, A. Uyttebroeck, M. Mangelschots, J. Falck Winther, JJ. Loonen, G. Michel, E. Bardi, L. Elmerdahl Frederiksen, J. den Hartogh, L. Mader, K. Roser, C. Schneider, MC. Brown, M. Brunhofer, I. Göttgens, RPMG. Hermens, A. Kienesberger, JC. Korevaar, R. Skinner, HJH. van der Pal, LCM. Kremer
- 520 9_
- $a BACKGROUND: Long-term follow-up (LTFU) care, although endorsed, is not available for the majority of adult survivors of childhood, adolescence and young adult (CAYA) cancer. Barriers to implementation include lack of time, knowledge, personnel and funding. Sustainable solutions are urgently needed to address the needs of CAYA cancer survivors to improve the quality of life and reduce the burden of late effects on survivors, health care systems and society. The European Union-funded PanCareFollowUp project, initiated by the Pan-European Network for Care of Survivors after Childhood and Adolescent Cancer, was established to facilitate the implementation of person-centred survivorship care across Europe. PATIENTS AND METHODS: The PanCareFollowUp Care Intervention was co-developed with survivors as part of the PanCareFollowUp project. It is a person-centred approach to survivorship care, supported by guidelines and with flexibility to adapt to local health care settings. The Care Intervention consists of three steps: (1) previsit completion of a Survivor Questionnaire (by the survivor) and Treatment Summary (by the health care provider [HCP]), (2) a clinic visit including shared decision-making, and (3) a follow-up call to finalise the individualised Survivorship Care Plan. RESULTS: We developed the key components of the PanCareFollowUp Care Intervention: a PanCareFollowUp Survivor Questionnaire, Treatment Summary template, Survivorship Care Plan template, and educational materials for HCPs and survivors. Wide implementation of the PanCareFollowUp Care Intervention will be supported with a freely distributed Replication Manual on completion of the PanCareFollowUp project. CONCLUSIONS: The PanCareFollowUp Care Intervention will support the implementation of person-centred, guideline-based LTFU care in different health care settings across Europe to improve survivors' health and well-being.
- 650 _2
- $a mladiství $7 D000293
- 650 12
- $a přežívající onkologičtí pacienti $7 D000073116
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory $x terapie $7 D009369
- 650 _2
- $a kvalita života $7 D011788
- 650 _2
- $a přežívající $7 D017741
- 650 _2
- $a období po vyléčení $7 D000073859
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Mulder, Renée L $u Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands
- 700 1_
- $a Haupt, Riccardo $u Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy
- 700 1_
- $a Muraca, Monica $u Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy
- 700 1_
- $a Hjorth, Lars $u Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Paediatrics, Lund, Sweden
- 700 1_
- $a Follin, Cecilia $u Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Oncology, Lund, Sweden
- 700 1_
- $a Kepak, Tomas $u International Clinical Research Centre (FNUSA-ICRC), St. Anne's University Hospital, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Kepáková, Kateřina, $u International Clinical Research Centre (FNUSA-ICRC), St. Anne's University Hospital, Masaryk University, Brno, Czech Republic $d 1972- $7 mzk2004246514
- 700 1_
- $a Uyttebroeck, Anne $u Department of Oncology, Paediatric Oncology, KU Leuven, Department of Paediatric Haematology and Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
- 700 1_
- $a Mangelschots, Marlies $u Department of Oncology, Paediatric Oncology, KU Leuven, Department of Paediatric Haematology and Oncology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
- 700 1_
- $a Falck Winther, Jeanette $u Childhood Cancer Research Group, Danish Cancer Society Research Centre, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health, Aarhus University Hospital, Aarhus University, Aarhus, Denmark
- 700 1_
- $a Loonen, Jacqueline J $u Department of Haematology, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, the Netherlands
- 700 1_
- $a Michel, Gisela $u Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland
- 700 1_
- $a Bardi, Edit $u PanCare, Bussum, the Netherlands; St Anna Children's Hospital, Vienna, Austria; Department of Pediatric and Adolescent Medicine, Kepler University Clinic, Linz, Austria
- 700 1_
- $a Elmerdahl Frederiksen, Line $u Childhood Cancer Research Group, Danish Cancer Society Research Centre, Copenhagen, Denmark
- 700 1_
- $a den Hartogh, Jaap $u PanCare, Bussum, the Netherlands; Childhood Cancer International Europe, Vienna, Austria
- 700 1_
- $a Mader, Luzius $u Childhood Cancer Research Group, Danish Cancer Society Research Centre, Copenhagen, Denmark; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland
- 700 1_
- $a Roser, Katharina $u Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland
- 700 1_
- $a Schneider, Carina $u Childhood Cancer International Europe, Vienna, Austria
- 700 1_
- $a Brown, Morven C $u Population Health Sciences Institute, Newcastle University, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom; Newcastle University Centre for Cancer, Wolfson Childhood Cancer Research Centre, Herschel Building, Newcastle Upon Tyne, United Kingdom
- 700 1_
- $a Brunhofer, Melanie $u Childhood Cancer International Europe, Vienna, Austria
- 700 1_
- $a Göttgens, Irene $u Department of Primary and Community Care, Radboud University Medical Centre, Radboud Institute for Health Sciences, Nijmegen, the Netherlands
- 700 1_
- $a Hermens, Rosella P M G $u Radboud University Medical Centre, Radboud Institute for Health Sciences, Scientific Institute for Quality of Healthcare (IQ Healthcare), Nijmegen, the Netherlands
- 700 1_
- $a Kienesberger, Anita $u Childhood Cancer International Europe, Vienna, Austria
- 700 1_
- $a Korevaar, Joke C $u Netherlands Institute for Health Services Research (Nivel), Utrecht, the Netherlands
- 700 1_
- $a Skinner, Roderick $u Newcastle University Centre for Cancer, Wolfson Childhood Cancer Research Centre, Herschel Building, Newcastle Upon Tyne, United Kingdom; Great North Children's Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom; Translational and Clinical Research Institute, Wolfson Childhood Cancer Research Centre, Herschel Building, Newcastle Upon Tyne, United Kingdom
- 700 1_
- $a van der Pal, Helena J H $u Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands; PanCare, Bussum, the Netherlands. Electronic address: H.J.H.vanderPal@prinsesmaximacentrum.nl
- 700 1_
- $a Kremer, Leontine C M $u Princess Máxima Centre for Paediatric Oncology, Utrecht, the Netherlands; Department of Paediatrics, Emma Children's Hospital, Amsterdam UMC, Amsterdam, the Netherlands; Faculty of Medicine, Utrecht University and Utrecht Medical Centre, Utrecht, the Netherlands
- 773 0_
- $w MED00009626 $t European journal of cancer $x 1879-0852 $g Roč. 162 (20211222), s. 34-44
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34953441 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20240219150830 $b ABA008
- 999 __
- $a ok $b bmc $g 1822845 $s 1170663
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 162 $c - $d 34-44 $e 20211222 $i 1879-0852 $m European journal of cancer $n Eur J Cancer $x MED00009626
- LZP __
- $a Pubmed-20220720
